Big Gain For MacroGenics, Inc.

Fri, Feb 17, 2023 at 07:18 PM
Big Gain For MacroGenics, Inc.

MacroGenics, Inc. (MGNX:NASDAQ) soared at $6.61, representing a gain of 25.7%. On Fri, Feb 17, 2023, MGNX:NASDAQ touched a New 2-Week High of $6.61. The stock appeared on our News Catalysts scanner on Tue, Feb 14, 2023 at 01:25 PM in the 'BIOTECH' category. From Fri, Feb 03, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Mon, Nov 14, 2022 at $7.57 with a volume of 1M+.

About MacroGenics, Inc. (MGNX:NASDAQ)

Macrogenics Inc is a clinical-stage biopharmaceutical company. It focusses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.